Renalys Pharma
About:
Renalys Pharma is a biopharmaceutical firm that develops therapeutics to improve the lives of patients facing renal issues.
Website: https://renalys.com
Top Investors: SR One, Nippon Venture Capital, Sumitomo Mitsui Trust Bank, Catalys Pacific, Japan Post Investment
Description:
Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
Total Funding Amount:
6B JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tokyo, Tokyo, Japan
Founded Date:
2023-01-01
Founders:
BT Slingsby, Takeshi Takahashi
Number of Employees:
11-50
Last Funding Date:
2024-07-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai